Orion Pharma Limited (DSE:ORIONPHARM)
31.50
-0.70 (-2.17%)
At close: Apr 9, 2025
Orion Pharma Revenue
Orion Pharma had revenue of 860.40M BDT in the quarter ending December 31, 2024, a decrease of -59.71%. This brings the company's revenue in the last twelve months to 7.38B, down -37.22% year-over-year. In the fiscal year ending June 30, 2024, Orion Pharma had annual revenue of 10.62B, down -23.74%.
Revenue (ttm)
7.38B
Revenue Growth
-37.22%
P/S Ratio
1.01
Revenue / Employee
2.34M
Employees
3,160
Market Cap
7.44B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 10.62B | -3.31B | -23.74% |
Jun 30, 2023 | 13.93B | 4.26B | 44.14% |
Jun 30, 2022 | 9.66B | -1.17B | -10.81% |
Jun 30, 2021 | 10.83B | 3.18B | 41.64% |
Jun 30, 2020 | 7.65B | -1.06B | -12.15% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Grameenphone | 158.45B |
Square Pharmaceuticals PLC. | 72.27B |
British American Tobacco Bangladesh Company | 93.12B |
Walton Hi-Tech Industries | 76.90B |
Robi Axiata PLC. | 99.50B |
Bangladesh Export Import Company | 17.72B |
BRAC Bank PLC. | 54.86B |
Berger Paints Bangladesh | 27.70B |